Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
9
×
ipo
9
×
life sciences
national blog main
venture capital
9
×
boston blog main
national top stories
san francisco blog main
texas blog main
texas top stories
cancer
new york blog main
san diego blog main
san diego top stories
san francisco top stories
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
new york top stories
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
vc
wisconsin blog main
wisconsin top stories
biogen
deals
fda
funding
novartis
startups
celgene
clinical trials
crispr
What
bio
ipo
roundup
medicine
medicines
cancer
covid
developing
help
million
new
plans
research
san
years
acquisitions
activity
advance
agent
alike
allogene
announced
antonio
approvals
badylak
becker
better
billions
biogen
biology
biopharma
car
celgene
ceo
clamped
collabs
colleagues
company
crispr
cytokine
Language
unset
Current search:
biotech
×
" venture capital "
×
ipo
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
San Antonio to Honor Regenerative Medicine Pioneer Stephen Badylak
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Bio Roundup: $74B for Celgene, Two CAR-T Tales, Ready for SF & More
@xconomy.com
5 years ago
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@xconomy.com
6 years ago
OncoNano, Maker of Tumor Imaging Technology, Raises $11.7 Million